Luseogliflozin, an SGLT2 Inhibitor, in Japanese Patients With Mild/Moderate Hepatic Impairment: A Pharmacokinetic Study
Samukawa, Yoshishige, Sata, Michio, Furihata, Kenichi, Ito, Toshifumi, Ueda, Naohiko, Ochiai, Hidekazu, Sakai, Soichi, Kumagai, YujiМова:
english
Журнал:
Clinical Pharmacology in Drug Development
DOI:
10.1002/cpdd.364
Date:
August, 2017
Файл:
PDF, 553 KB
english, 2017
File converter
Більше результатів пошуку
More benefits 
